Pfizer Inc. logo PFE - Pfizer Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 15
HOLD 23
SELL 1
STRONG
SELL 0
| PRICE TARGET: $27.33 DETAILS
HIGH: $31.00
LOW: $25.00
MEDIAN: $27.00
CONSENSUS: $27.33
UPSIDE: 3.24%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Fair Value Mild
Trading 14.9% below fair value
Current Price $26.47
Bear Case $26.65 0.7% upside ($26.65 - $26.47) / $26.47 = 0.7% $2.34 × 12x P/E
Fair Value $31.10 17.5% upside ($31.10 - $26.47) / $26.47 = 17.5% $2.34 × 14x P/E
Bull Case $35.54 34.2% upside ($35.54 - $26.47) / $26.47 = 34.2% $2.34 × 16x P/E

Adjust Assumptions

14.0x
2.34$

Key Value Driver

Normalized P/E multiple (14x base case)

Implied Market Multiple 11.3x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $27.33 from 39 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $31.10 per share.

Warnings

⚠ The company's reported profits differ from official accounting profits by 72%. Check what costs are being left out of the adjusted number.
⚠ The company pays out 126% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples